Carlos Paya V - 06 Jun 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
Carlos V. Paya, by /s/ Peter N. Efremenko, Attorney-In-Fact
Issuer symbol
PCVX
Transactions as of
06 Jun 2024
Net transactions value
$0
Form type
4
Filing time
10 Jun 2024, 16:05:43 UTC
Previous filing
09 Nov 2023
Next filing
10 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Award $0 +1,550 +62% $0.000000 4,050 06 Jun 2024 Direct F1
holding PCVX Common Stock 3,125 06 Jun 2024 By Family Trust F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +7,250 $0.000000 7,250 06 Jun 2024 Common Stock 7,250 $72.51 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs will fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.
F2 Shares are held directly by a trust for the sole benefit of the Reporting Person.
F3 The shares of Common Stock subject to the option will vest monthly and fully vest on the earlier of June 6, 2025 or the day prior to the next annual meeting of stockholders, subject to acceleration, and subject to the Reporting Person's continuous service through such date.